Compare TBLA & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBLA | ATRC |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | United States | United States |
| Employees | 2000 | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | TBLA | ATRC |
|---|---|---|
| Price | $5.57 | $34.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $5.00 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 3.9M | 1.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | $7.63 | $15.27 |
| Revenue Next Year | $5.25 | $12.21 |
| P/E Ratio | $42.36 | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $2.84 | $25.36 |
| 52 Week High | $5.71 | $43.18 |
| Indicator | TBLA | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 66.56 | 70.23 |
| Support Level | $3.86 | $34.16 |
| Resistance Level | N/A | $34.38 |
| Average True Range (ATR) | 0.24 | 1.50 |
| MACD | 0.07 | 0.62 |
| Stochastic Oscillator | 89.02 | 91.94 |
Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.